Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Cohesin-mutant hematologic malignancies have distinct illness traitsWe investigated 2 giant cohorts of sufferers recognized with a hematologic malignancy for presence of a mutation...
HOLLAND TWP. — Emerson Hoogendoorn, generally known as Emerson the Courageous, died Thursday, July 18, after a six-year battle with most cancers.Emerson, 12,...
